Search results
Vascular Biogenics (VBLT) Down, Ovarian Cancer Study Fails
Zacks via Yahoo Finance· 2 years agoVascular Biogenics' (VBLT) phase III OVAL study, evaluating ofra-vec in patients with...
Analysts Estimate Vascular Biogenics (VBLT) to Report a Decline in Earnings: What to Look Out for
Zacks via Yahoo Finance· 2 years agoVascular Biogenics (VBLT) doesn't possess the right combination of the two key ingredients for a...
Vascular Biogenics (VBLT) Reports Q2 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 2 years agoVascular Biogenics (VBLT) delivered earnings and revenue surprises of 7.69% and 57.33%,...
Vascular Biogenics Full Year 2022 Earnings: US$0.42 loss per share (vs US$0.45 loss in FY 2021)
Simply Wall St. via Yahoo Finance· 1 year agoVascular Biogenics (NASDAQ:VBLT) Full Year 2022 Results Key Financial Results Net loss: US$32.3m...
Read Why VBL Therapeutics Shares Are Falling To a 52-Week Low
Benzinga via Yahoo Finance· 2 years agoVascular Biogenics Ltd or VBL Therapeutics (NASDAQ: VBLT) announced topline data from the Phase 3...
Sorrento (SRNE) Gets FDA Fast Track Tag for Back Pain Product
Zacks via Yahoo Finance· 2 years agoSorrento Therapeutics’ SRNE subsidiary Scilex Holding Company recently received Fast Track...
Axsome (AXSM) Starts Late-Stage Study of Migraine Drug AXS-07
Zacks via Yahoo Finance· 2 years agoAxsome AXSM announced the enrollment of the first patient in the EMERGE phase III open label study...
Pliant (PLRX) Receives Positive Review of IPF Study at Top Dose
Zacks via Yahoo Finance· 2 years agoPliant (PLRX) receives a positive DSMB review of the ongoing mid-stage study evaluating the...
Vascular Biogenics: Q1 Earnings Snapshot
AP Finance via Yahoo Finance· 1 year agoMODI`IN , Israel (AP) — MODI`IN, Israel (AP) — Vascular Biogenics Ltd. (VBLT) on Monday reported a loss of $2.6 million in its first quarter. On a per-share basis, the Modi`In, Israel-based ...
13 Best Biotech Penny Stocks To Buy Now
Insider Monkey via Yahoo Finance· 1 year agoIn this article, we will be taking a look at the 13 best biotech penny stocks to buy now. To skip our detailed analysis of these stocks, you can go...
